![CR7 CR7](https://data.pdbj.org/pdbjplus/data/cc/svg/CR7.svg) | CR7 | 表記: | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | 組成式: | C17 H22 N4 O4 | SMILES: | O=C1C(N=C(N1CC(=O)O)C(N)CCCCN)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C17H22N4O4/c18-8-2-1-3-13(19)16-20-14(17(25)21(16)10-15(23)24)9-11-4-6-12(22)7-5-11/h4-7,9,13,22H,1-3,8,10,18-19H2,(H,23,24)/b14-9-/t13-/m0/s1 | 別名: | CHROMOPHORE (LYS-TYR-GLY) | 定義日: | 2005-07-01 | 最終更新日: | 2023-11-03 | 識別子(ID): | {(4Z)-2-[(1S)-1,5-diaminopentyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
![CR8 CR8](https://data.pdbj.org/pdbjplus/data/cc/svg/CR8.svg) | CR8 | 表記: | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]-1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA-2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL-5-OLATE | 組成式: | C17 H16 N5 O4 | SMILES: | O=C1C=C/C(C=C1)=Cc2nc(n(c2[O-])CC(=O)O)C(N)Cc3cncn3 | InChi: | InChI=1S/C17H17N5O4/c18-13(6-11-7-19-9-20-11)16-21-14(17(26)22(16)8-15(24)25)5-10-1-3-12(23)4-2-10/h1-5,7,9,13,26H,6,8,18H2,(H,19,20)(H,24,25)/p-1/t13-/m0/s1 | 別名: | CHROMOPHORE (HIS-TYR-GLY) | 定義日: | 2005-06-14 | 最終更新日: | 2023-11-03 | 識別子(ID): | 2-[(1S)-1-amino-2-(1H-imidazol-5-yl)ethyl]-1-(carboxymethyl)-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-1H-imidazol-5-olate |
|
![CRF CRF](https://data.pdbj.org/pdbjplus/data/cc/svg/CRF.svg) | CRF | 表記: | [(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(1H-indol-3-ylmethylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid | 組成式: | C17 H18 N4 O4 | SMILES: | C[CH](O)[CH](N)C1=NC(=Cc2c[nH]c3ccccc23)C(=O)N1CC(O)=O | InChi: | InChI=1S/C17H18N4O4/c1-9(22)15(18)16-20-13(17(25)21(16)8-14(23)24)6-10-7-19-12-5-3-2-4-11(10)12/h2-7,9,15,19,22H,8,18H2,1H3,(H,23,24)/b13-6-/t9-,15+/m1/s1 | 定義日: | 2003-09-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | 2-[2-[(1R,2R)-1-azanyl-2-hydroxy-propyl]-4-(1H-indol-3-ylmethylidene)-5-oxo-imidazol-1-yl]ethanoic acid |
|
![CRG CRG](https://data.pdbj.org/pdbjplus/data/cc/svg/CRG.svg) | CRG | 表記: | [2-(1-AMINO-2-HYDROXY-PROPYL)-4-(3H-IMIDAZOL-4-YLMETHYLENE)-5-OXO-4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | 組成式: | C12 H15 N5 O4 | SMILES: | O=C1C(N=C(N1CC(=O)O)C(N)C(O)C)=Cc2ncnc2 | InChi: | InChI=1S/C12H15N5O4/c1-6(18)10(13)11-16-8(2-7-3-14-5-15-7)12(21)17(11)4-9(19)20/h2-3,5-6,10,18H,4,13H2,1H3,(H,14,15)(H,19,20)/b8-2-/t6-,10+/m1/s1 | 定義日: | 2002-02-20 | 最終更新日: | 2023-11-03 | 識別子(ID): | [(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(1H-imidazol-4-ylmethylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
![CRO CRO](https://data.pdbj.org/pdbjplus/data/cc/svg/CRO.svg) | CRO | 表記: | {2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 組成式: | C15 H17 N3 O5 | SMILES: | O=C1C(N=C(N1CC(=O)O)C(N)C(O)C)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C15H17N3O5/c1-8(19)13(16)14-17-11(15(23)18(14)7-12(21)22)6-9-2-4-10(20)5-3-9/h2-6,8,13,19-20H,7,16H2,1H3,(H,21,22)/b11-6-/t8-,13+/m1/s1 | 別名: | PEPTIDE DERIVED CHROMOPHORE | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | [(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
![CRQ CRQ](https://data.pdbj.org/pdbjplus/data/cc/svg/CRQ.svg) | CRQ | 表記: | [2-(3-CARBAMOYL-1-IMINO-PROPYL)-4-(4-HYDROXY-BENZYLIDENE)-5-OXO-4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | 組成式: | C16 H16 N4 O5 | SMILES: | O=C1C(N=C(C(=[N@H])CCC(=O)N)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C16H16N4O5/c17-11(5-6-13(18)22)15-19-12(16(25)20(15)8-14(23)24)7-9-1-3-10(21)4-2-9/h1-4,7,17,21H,5-6,8H2,(H2,18,22)(H,23,24)/b12-7-,17-11+ | 別名: | CHROMOPHORE (GLN-TYR-GLY) | 定義日: | 2000-10-19 | 最終更新日: | 2023-11-03 | 識別子(ID): | [(4Z)-2-[(1E)-4-amino-4-oxobutanimidoyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
![CRU CRU](https://data.pdbj.org/pdbjplus/data/cc/svg/CRU.svg) | CRU | 表記: | 4-[(4Z)-1-(CARBOXYMETHYL)-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-2-YL]-4-IMINOBUTANOIC ACID | 組成式: | C16 H15 N3 O6 | SMILES: | O=C1C(N=C(C(=[N@H])CCC(=O)O)N1CC(=O)O)=C/c2ccc(O)cc2 | InChi: | InChI=1S/C16H15N3O6/c17-11(5-6-13(21)22)15-18-12(16(25)19(15)8-14(23)24)7-9-1-3-10(20)4-2-9/h1-4,7,17,20H,5-6,8H2,(H,21,22)(H,23,24)/b12-7+,17-11- | 別名: | CHROMOPHORE (GLU-TYR-GLY) | 定義日: | 2005-03-03 | 最終更新日: | 2023-11-03 | 識別子(ID): | (4Z)-4-[(4E)-1-(carboxymethyl)-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-2-yl]-4-iminobutanoic acid |
|
![CRX CRX](https://data.pdbj.org/pdbjplus/data/cc/svg/CRX.svg) | CRX | 表記: | [2-(1-AMINOETHYL)-2-HYDROXY-4-METHYLENE-5-OXOIMIDAZOLIDIN-1-YL]ACETIC ACID | 組成式: | C8 H13 N3 O4 | SMILES: | O=C(O)CN1C(=O)/C(NC1(O)C(N)C)=C | InChi: | InChI=1S/C8H13N3O4/c1-4-7(14)11(3-6(12)13)8(15,10-4)5(2)9/h5,10,15H,1,3,9H2,2H3,(H,12,13)/t5-,8+/m0/s1 | 別名: | CHROMOPHORE (ALA-SER-GLY) | 定義日: | 2005-01-28 | 最終更新日: | 2023-11-03 | 識別子(ID): | {(2R)-2-[(1S)-1-aminoethyl]-2-hydroxy-4-methylidene-5-oxoimidazolidin-1-yl}acetic acid |
|
![CSH CSH](https://data.pdbj.org/pdbjplus/data/cc/svg/CSH.svg) | CSH | 表記: | [2-(2-HYDROXY-1-METHYL-ETHYL)-4-(1H-IMIDAZOL-4-YLMETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID | 組成式: | C11 H17 N5 O4 | SMILES: | O=C1N(CC(=O)O)C(NC1Cc2ncnc2)C(N)CO | InChi: | InChI=1S/C11H17N5O4/c12-7(4-17)10-15-8(1-6-2-13-5-14-6)11(20)16(10)3-9(18)19/h2,5,7-8,10,15,17H,1,3-4,12H2,(H,13,14)(H,18,19)/t7-,8-,10-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | [(2S,4S)-2-[(1R)-1-amino-2-hydroxyethyl]-4-(1H-imidazol-4-ylmethyl)-5-oxoimidazolidin-1-yl]acetic acid |
|
![CSI CSI](https://data.pdbj.org/pdbjplus/data/cc/svg/CSI.svg) | CSI | 表記: | AMINO-(2-IMINO-HEXAHYDRO-PYRIMIDIN-4-YL)-ACETIC ACID | 組成式: | C7 H12 N4 O4 | SMILES: | N1C(=N)NC(CC1)C(NC(=O)O)C(=O)O | InChi: | InChI=1S/C7H12N4O4/c8-6-9-2-1-3(10-6)4(5(12)13)11-7(14)15/h3-4,11H,1-2H2,(H,12,13)(H,14,15)(H3,8,9,10)/t3-,4+/m1/s1 | 定義日: | 2001-11-28 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2S)-(carboxyamino)[(2Z,4R)-2-iminohexahydropyrimidin-4-yl]acetic acid |
|
![CTE CTE](https://data.pdbj.org/pdbjplus/data/cc/svg/CTE.svg) | CTE | 表記: | 7-CHLOROTRYPTOPHAN | 組成式: | C11 H11 Cl N2 O2 | SMILES: | O=C(O)C(N)Cc2c1cccc(Cl)c1nc2 | InChi: | InChI=1S/C11H11ClN2O2/c12-8-3-1-2-7-6(5-14-10(7)8)4-9(13)11(15)16/h1-3,5,9,14H,4,13H2,(H,15,16)/t9-/m0/s1 | 定義日: | 2005-08-31 | 最終更新日: | 2023-11-03 | 識別子(ID): | 7-chloro-L-tryptophan |
|
![CUD CUD](https://data.pdbj.org/pdbjplus/data/cc/svg/CUD.svg) | CUD | 表記: | 3-(4-amino-2-oxopyrimidin-1(2H)-yl)-D-alanine | 組成式: | C7 H10 N4 O3 | SMILES: | O=C1N=C(C=CN1CC(C(=O)O)N)N | InChi: | InChI=1S/C7H10N4O3/c8-4(6(12)13)3-11-2-1-5(9)10-7(11)14/h1-2,4H,3,8H2,(H,12,13)(H2,9,10,14)/t4-/m1/s1 | 定義日: | 2008-02-12 | 最終更新日: | 2023-11-03 | 識別子(ID): | 3-(4-amino-2-oxopyrimidin-1(2H)-yl)-D-alanine |
|
![CYJ CYJ](https://data.pdbj.org/pdbjplus/data/cc/svg/CYJ.svg) | CYJ | 表記: | (Z)-N~6~-[(4R,5S)-5-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)PIPERIDIN-3-YLIDENE]-L-LYSINE | 組成式: | C16 H27 N3 O6 | SMILES: | O=C(O)C(N)CCCC/N=C1/CNCC(CCC(=O)O)C1CC(=O)O | InChi: | InChI=1S/C16H27N3O6/c17-12(16(24)25)3-1-2-6-19-13-9-18-8-10(4-5-14(20)21)11(13)7-15(22)23/h10-12,18H,1-9,17H2,(H,20,21)(H,22,23)(H,24,25)/b19-13-/t10-,11-,12+/m1/s1 | 別名: | 2-AMINO-6-(3-CARBOXY-1-[(4-CARBOXY-2-OXO-BUTYLAMINO)-METHYL]-PROPYLIDENEAMINO)-HEXANOIC ACID | 定義日: | 2005-09-11 | 最終更新日: | 2023-11-03 | 識別子(ID): | (E)-N~6~-[(4R,5S)-5-(2-carboxyethyl)-4-(carboxymethyl)piperidin-3-ylidene]-L-lysine |
|
![CZO CZO](https://data.pdbj.org/pdbjplus/data/cc/svg/CZO.svg) | CZO | 表記: | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]-2-hydroxy-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid | 組成式: | C15 H21 N3 O6 | SMILES: | O=C1N(CC(=O)O)C(O)(NC1Cc2ccc(O)cc2)C(N)C(O)C | InChi: | InChI=1S/C15H21N3O6/c1-8(19)13(16)15(24)17-11(14(23)18(15)7-12(21)22)6-9-2-4-10(20)5-3-9/h2-5,8,11,13,17,19-20,24H,6-7,16H2,1H3,(H,21,22)/t8-,11+,13+,15-/m1/s1 | 定義日: | 2008-12-17 | 最終更新日: | 2023-11-03 | 識別子(ID): | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]-2-hydroxy-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid |
|
![CZS CZS](https://data.pdbj.org/pdbjplus/data/cc/svg/CZS.svg) | CZS | 表記: | 3-(6-chloro-1,3-benzothiazol-2-yl)-L-alanine | 組成式: | C10 H9 Cl N2 O2 S | SMILES: | NC(Cc2sc1cc(Cl)ccc1n2)C(=O)O | InChi: | InChI=1S/C10H9ClN2O2S/c11-5-1-2-7-8(3-5)16-9(13-7)4-6(12)10(14)15/h1-3,6H,4,12H2,(H,14,15)/t6-/m0/s1 | 定義日: | 2017-10-09 | 最終更新日: | 2023-11-03 | 公開日: | 2018-02-28 | 識別子(ID): | 3-(6-chloro-1,3-benzothiazol-2-yl)-L-alanine |
|
![D0Q D0Q](https://data.pdbj.org/pdbjplus/data/cc/svg/D0Q.svg) | D0Q | 表記: | 5-methyl-L-tryptophan | 組成式: | C12 H14 N2 O2 | SMILES: | Cc1ccc2[nH]cc(C[CH](N)C(O)=O)c2c1 | InChi: | InChI=1S/C12H14N2O2/c1-7-2-3-11-9(4-7)8(6-14-11)5-10(13)12(15)16/h2-4,6,10,14H,5,13H2,1H3,(H,15,16)/t10-/m0/s1 | 定義日: | 2017-12-15 | 最終更新日: | 2023-11-03 | 公開日: | 2019-01-30 | 識別子(ID): | (2~{S})-2-azanyl-3-(5-methyl-1~{H}-indol-3-yl)propanoic acid |
|
![DYG DYG](https://data.pdbj.org/pdbjplus/data/cc/svg/DYG.svg) | DYG | 表記: | (3S)-3-amino-3-[(4Z)-1-(carboxymethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxo-imidazol-2-yl]propanoic acid | 組成式: | C15 H15 N3 O6 | SMILES: | O=C(O)CC(N)C1=N/C(C(=O)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C15H15N3O6/c16-10(6-12(20)21)14-17-11(15(24)18(14)7-13(22)23)5-8-1-3-9(19)4-2-8/h1-5,10,19H,6-7,16H2,(H,20,21)(H,22,23)/b11-5-/t10-/m0/s1 | 別名: | CHROMOPHORE (ASP-TYR-GLY) | 定義日: | 2004-10-25 | 最終更新日: | 2023-11-03 | 識別子(ID): | (3S)-3-amino-3-{(4Z)-1-(carboxymethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-2-yl}propanoic acid |
|
![E03 E03](https://data.pdbj.org/pdbjplus/data/cc/svg/E03.svg) | E03 | 表記: | 6-FLUORO-D-TRYPTOPHAN | 組成式: | C11 H11 F N2 O2 | SMILES: | N[CH](Cc1c[nH]c2cc(F)ccc12)C(O)=O | InChi: | InChI=1S/C11H11FN2O2/c12-7-1-2-8-6(3-9(13)11(15)16)5-14-10(8)4-7/h1-2,4-5,9,14H,3,13H2,(H,15,16)/t9-/m1/s1 | 別名: | (2R)-2-azanyl-3-(6-fluoranyl-1H-indol-3-yl)propanoic acid | 定義日: | 2019-09-27 | 最終更新日: | 2023-11-03 | 公開日: | 2019-10-16 | 識別子(ID): | (2~{R})-2-azanyl-3-(6-fluoranyl-1~{H}-indol-3-yl)propanoic acid |
|
![E2G E2G](https://data.pdbj.org/pdbjplus/data/cc/svg/E2G.svg) | E2G | 表記: | (2R)-N-[(4-{2-[(acetylamino)methyl]phenyl}-5-methyl-4H-1,2,4-triazol-3-yl)methyl]-2-amino-2-hydroxyacetamide | 組成式: | C15 H20 N6 O3 | SMILES: | C(NC(C(N)O)=O)c1nnc(C)n1c2c(cccc2)CNC(C)=O | InChi: | InChI=1S/C15H20N6O3/c1-9-19-20-13(8-18-15(24)14(16)23)21(9)12-6-4-3-5-11(12)7-17-10(2)22/h3-6,14,23H,7-8,16H2,1-2H3,(H,17,22)(H,18,24)/t14-/m1/s1 | 定義日: | 2017-11-27 | 最終更新日: | 2023-11-03 | 公開日: | 2017-12-27 | 識別子(ID): | (2R)-N-[(4-{2-[(acetylamino)methyl]phenyl}-5-methyl-4H-1,2,4-triazol-3-yl)methyl]-2-amino-2-hydroxyacetamide |
|
![E95 E95](https://data.pdbj.org/pdbjplus/data/cc/svg/E95.svg) | E95 | 表記: | 7-Methyl-L-Tryptophan | 組成式: | C12 H14 N2 O2 | SMILES: | Cc1cccc2c(C[CH](N)C(O)=O)c[nH]c12 | InChi: | InChI=1S/C12H14N2O2/c1-7-3-2-4-9-8(6-14-11(7)9)5-10(13)12(15)16/h2-4,6,10,14H,5,13H2,1H3,(H,15,16)/t10-/m0/s1 | 定義日: | 2018-03-06 | 最終更新日: | 2023-11-03 | 公開日: | 2019-02-13 | 識別子(ID): | (2~{S})-2-azanyl-3-(7-methyl-1~{H}-indol-3-yl)propanoic acid |
|
![E9C E9C](https://data.pdbj.org/pdbjplus/data/cc/svg/E9C.svg) | E9C | 表記: | (2S)-2-azanyl-3-[3,4,6-tris(oxidanylidene)cyclohexen-1-yl]propanoic acid | 組成式: | C9 H9 N O5 | SMILES: | N[CH](CC1=CC(=O)C(=O)C(C1=O)([2H])[2H])C(O)=O | InChi: | InChI=1S/C9H9NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2,5H,1,3,10H2,(H,14,15)/t5-/m0/s1/i3D2 | 定義日: | 2019-11-22 | 最終更新日: | 2023-11-03 | 公開日: | 2020-04-29 | 識別子(ID): | (2~{S})-2-azanyl-3-[3,4,6-tris(oxidanylidene)cyclohexen-1-yl]propanoic acid |
|
![E9M E9M](https://data.pdbj.org/pdbjplus/data/cc/svg/E9M.svg) | E9M | 表記: | N-methyl-L-tryptophan | 組成式: | C12 H14 N2 O2 | SMILES: | N(C)C(Cc1cnc2c1cccc2)C(=O)O | InChi: | InChI=1S/C12H14N2O2/c1-13-11(12(15)16)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,13-14H,6H2,1H3,(H,15,16)/t11-/m0/s1 | 定義日: | 2017-12-14 | 最終更新日: | 2023-11-03 | 公開日: | 2018-12-19 | 識別子(ID): | N-methyl-L-tryptophan |
|
![FZN FZN](https://data.pdbj.org/pdbjplus/data/cc/svg/FZN.svg) | FZN | 表記: | (2S)-2-amino-6-{[(1Z)-1-{[(2R,3R,4S,5R)-5-({[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxytetrahydrofuran-2-yl]sulfanyl}ethylidene]amino}hexanoic acid | 組成式: | C23 H37 N7 O15 P2 S | SMILES: | O=P(O)(OCC3OC(n1c2ncnc(N)c2nc1)C(O)C3O)OP(=O)(O)OCC4OC(SC(=N/CCCCC(C(=O)O)N)C)C(O)C4O | InChi: | InChI=1S/C23H37N7O15P2S/c1-10(26-5-3-2-4-11(24)22(35)36)48-23-18(34)16(32)13(44-23)7-42-47(39,40)45-46(37,38)41-6-12-15(31)17(33)21(43-12)30-9-29-14-19(25)27-8-28-20(14)30/h8-9,11-13,15-18,21,23,31-34H,2-7,24H2,1H3,(H,35,36)(H,37,38)(H,39,40)(H2,25,27,28)/b26-10-/t11-,12+,13+,15+,16+,17+,18+,21+,23+/m0/s1 | 定義日: | 2008-06-18 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2S)-2-amino-6-{[(1Z)-1-{[(2R,3R,4S,5R)-5-({[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxytetrahydrofuran-2-yl]sulfanyl}ethylidene]amino}hexanoic acid (non-preferred name) |
|
![G1X G1X](https://data.pdbj.org/pdbjplus/data/cc/svg/G1X.svg) | G1X | 表記: | (2S)-2-azanyl-3-[3,4-bis(oxidanylidene)cyclohexa-1,5-dien-1-yl]propanoic acid | 組成式: | C9 H9 N O4 | SMILES: | N[CH](CC1=CC(=O)C(=O)C=C1)C(O)=O | InChi: | InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1 | 別名: | L-dopaquinone | 定義日: | 2020-07-15 | 最終更新日: | 2023-11-03 | 公開日: | 2021-06-16 | 識別子(ID): | (2~{S})-2-azanyl-3-[3,4-bis(oxidanylidene)cyclohexa-1,5-dien-1-yl]propanoic acid |
|
![DM0 DM0](https://data.pdbj.org/pdbjplus/data/cc/svg/DM0.svg) | DM0 | 表記: | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine | 組成式: | C10 H22 N2 O2 | SMILES: | O=C(O)C(N(C)C)CCCCN(C)C | InChi: | InChI=1S/C10H22N2O2/c1-11(2)8-6-5-7-9(10(13)14)12(3)4/h9H,5-8H2,1-4H3,(H,13,14)/t9-/m0/s1 | 定義日: | 2008-03-25 | 最終更新日: | 2023-11-03 | 識別子(ID): | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine |
|